Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.30

EBS Q1 2016 Earnings — Emergent BioSolutions Inc. Revenue & Financial Results | Market Cap Arena

EBSEmergent BioSolutions Inc.

$430M

Q1 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$103M

Gross Profit

$54M52.1% margin

Operating Income

$21M20.5% margin

Net Income

$4M3.9% margin

EPS (Diluted)

$0.10

Cash Flow

Operating Cash Flow

$38M

Free Cash Flow

$20M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$369M

Stockholders' Equity

$667M

Cash & Equivalents

$341M

← FY 2016 All Quarters Q2 2016 →